PE21995A1 - Derivado de 2-carboxiindol - Google Patents

Derivado de 2-carboxiindol

Info

Publication number
PE21995A1
PE21995A1 PE1994252640A PE25264094A PE21995A1 PE 21995 A1 PE21995 A1 PE 21995A1 PE 1994252640 A PE1994252640 A PE 1994252640A PE 25264094 A PE25264094 A PE 25264094A PE 21995 A1 PE21995 A1 PE 21995A1
Authority
PE
Peru
Prior art keywords
derivative
adylene
carboxyindol
amino
stricnin
Prior art date
Application number
PE1994252640A
Other languages
English (en)
Spanish (es)
Inventor
Alfredo Cugola
Giorgio Pentassuglia
Di Fabio Romano
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of PE21995A1 publication Critical patent/PE21995A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
PE1994252640A 1993-10-14 1994-10-12 Derivado de 2-carboxiindol PE21995A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939321221A GB9321221D0 (en) 1993-10-14 1993-10-14 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
PE21995A1 true PE21995A1 (es) 1995-08-14

Family

ID=10743550

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1994252640A PE21995A1 (es) 1993-10-14 1994-10-12 Derivado de 2-carboxiindol

Country Status (27)

Country Link
US (3) US5760059A (OSRAM)
EP (1) EP0723541A1 (OSRAM)
JP (1) JPH09503770A (OSRAM)
CN (1) CN1070490C (OSRAM)
AP (1) AP574A (OSRAM)
AU (1) AU681194B2 (OSRAM)
BG (1) BG61839B1 (OSRAM)
CA (1) CA2171449A1 (OSRAM)
CO (1) CO4290355A1 (OSRAM)
CZ (1) CZ92396A3 (OSRAM)
FI (1) FI961628A7 (OSRAM)
GB (1) GB9321221D0 (OSRAM)
HU (1) HU219710B (OSRAM)
IL (1) IL111294A (OSRAM)
IS (1) IS4219A (OSRAM)
MY (1) MY112411A (OSRAM)
NO (1) NO309861B1 (OSRAM)
NZ (1) NZ274179A (OSRAM)
OA (1) OA10578A (OSRAM)
PE (1) PE21995A1 (OSRAM)
PL (1) PL179568B1 (OSRAM)
RU (1) RU2144535C1 (OSRAM)
SG (1) SG49013A1 (OSRAM)
SK (1) SK44996A3 (OSRAM)
TW (1) TW283144B (OSRAM)
WO (1) WO1995010517A1 (OSRAM)
ZA (1) ZA947948B (OSRAM)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds
GB9704498D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Chemical compound
GB9704499D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Method of manufacture
EP1163220A1 (en) * 1999-03-23 2001-12-19 Sumitomo Pharmaceuticals Company, Limited Tricyclic indole-2-carboxylic acid compound used as nmda receptor antagonist
RU2209041C2 (ru) * 2000-06-15 2003-07-27 Новосибирский научно-исследовательский институт травматологии и ортопедии Способ лечения церебрального вазоспазма
DE10153346A1 (de) 2001-10-29 2004-04-22 Grünenthal GmbH Substituierte Indole
WO2003039540A2 (en) * 2001-11-09 2003-05-15 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
CZ2006427A3 (cs) 2003-12-29 2006-11-15 Sepracor Inc. Pyrrolové a pyrazolové inhibitory DAAO
US20080293726A1 (en) 2005-07-06 2008-11-27 Sepracor Inc. Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders
WO2007063010A1 (en) * 2005-12-01 2007-06-07 F. Hoffmann-La Roche Ag Novel vinylogous acids derivatives
CN101426372A (zh) * 2006-01-06 2009-05-06 塞普拉柯公司 基于四氢萘酮的单胺再摄取抑制剂
BRPI0706365A2 (pt) * 2006-01-06 2011-03-22 Sepracor Inc Cicloalquilaminas como inibidores da recaptação de monoamina
CN103588659A (zh) 2006-03-31 2014-02-19 赛诺维信制药公司 手性酰胺和胺的制备
US7579370B2 (en) * 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
US7884124B2 (en) * 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US20080082066A1 (en) * 2006-10-02 2008-04-03 Weyerhaeuser Co. Crosslinked carboxyalkyl cellulose fibers having non-permanent and temporary crosslinks
BRPI0806604A2 (pt) * 2007-01-18 2011-09-06 Sepracor Inc inibidores de d-aminoácido oxidase
US7902252B2 (en) * 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
BRPI0811639A2 (pt) 2007-05-31 2014-09-30 Sepracor Inc Cicloaquilaminas fenil substituídas como inibidores da recaptação de monoamina
WO2010017418A1 (en) * 2008-08-07 2010-02-11 Sepracor Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
WO2010104093A1 (ja) 2009-03-10 2010-09-16 参天製薬株式会社 4,6-ジクロロ-1h-インドール-2-カルボン酸誘導体又はその塩を有効成分として含有する視神経障害の予防又は治療剤
US20110034434A1 (en) * 2009-08-07 2011-02-10 Sepracor Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
WO2013055386A2 (en) 2011-10-03 2013-04-18 The University Of Utah Research Foundation Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome
IL248567B (en) 2014-04-30 2022-08-01 Univ Nat Taiwan Use of known compounds as d-amino acid oxidase inhibitors
AU2017326359B2 (en) 2016-09-14 2021-02-04 National Chiao Tung University Novel substituted benzimidazole derivatives as D-amino acid oxidase (DAAO) inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256673A (en) * 1983-11-25 1993-10-26 Merck Patent Gesellschaft Mit Beschrankter Haftung Indole-3-yl-A-tetrahydropyridyl or piperidyl compounds
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
JPH0347123A (ja) * 1989-05-05 1991-02-28 G D Searle & Co インドール―2―カルボキシレート化合物類を含有するcns疾患治療用組成物
DE4101686A1 (de) * 1991-01-22 1992-07-23 Merck Patent Gmbh Indolderivate
US5284862A (en) * 1991-03-18 1994-02-08 Warner-Lambert Company Derivatives of 2-carboxyindoles having pharmaceutical activity
US5145845A (en) * 1991-05-14 1992-09-08 Warner-Lambert Co. Substituted 2-carboxylindoles having pharmaceutical activity
EP0545478A1 (en) * 1991-12-03 1993-06-09 MERCK SHARP & DOHME LTD. Heterocyclic compounds as tachykinin antagonists
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
CZ181493A3 (en) * 1992-09-10 1994-03-16 Lilly Co Eli The use of rhodanine derivative for the preparation of a pharmaceutical composition reducing level of sugar in blood and for treating alzheimer's disease
DE4333254A1 (de) * 1993-09-30 1995-04-06 Merck Patent Gmbh Piperidine und Piperazine
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds

Also Published As

Publication number Publication date
SK44996A3 (en) 1997-01-08
HU9600969D0 (en) 1996-06-28
IL111294A0 (en) 1994-12-29
JPH09503770A (ja) 1997-04-15
HUT76065A (en) 1997-06-30
RU2144535C1 (ru) 2000-01-20
PL313969A1 (en) 1996-08-05
EP0723541A1 (en) 1996-07-31
OA10578A (en) 2002-06-07
HU219710B (hu) 2001-06-28
NO309861B1 (no) 2001-04-09
GB9321221D0 (en) 1993-12-01
US6100289A (en) 2000-08-08
SG49013A1 (en) 1998-05-18
CO4290355A1 (es) 1996-04-17
BG100511A (en) 1996-11-29
US5962496A (en) 1999-10-05
IL111294A (en) 1998-12-06
CN1070490C (zh) 2001-09-05
ZA947948B (en) 1995-05-23
NO961475D0 (no) 1996-04-12
AU7813394A (en) 1995-05-04
PL179568B1 (pl) 2000-09-29
AP9400685A0 (en) 1994-10-31
CN1133042A (zh) 1996-10-09
AU681194B2 (en) 1997-08-21
MY112411A (en) 2001-06-30
IS4219A (is) 1995-04-15
AP574A (en) 1997-01-30
CA2171449A1 (en) 1995-04-20
US5760059A (en) 1998-06-02
FI961628A0 (fi) 1996-04-12
FI961628A7 (fi) 1996-04-12
TW283144B (OSRAM) 1996-08-11
WO1995010517A1 (en) 1995-04-20
CZ92396A3 (en) 1996-08-14
NZ274179A (en) 1998-01-26
BG61839B1 (bg) 1998-07-31
NO961475L (no) 1996-04-12

Similar Documents

Publication Publication Date Title
PE21995A1 (es) Derivado de 2-carboxiindol
PE20010741A1 (es) Derivados de piperazina como antagonistas de taquicininas
DE69319235D1 (de) Perhydroisoindole derivate als substanz p antagonisten
FI913503A0 (fi) Bensimidazoler, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
YU45293A (sh) Morfolin i tiomorfolin tahikinin antagonisti receptora
EA200300717A1 (ru) Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
ATE184874T1 (de) Fibrinogen-rezeptor-antagonisten
ATE163646T1 (de) Fibrinogen-rezeptor-antagonisten
ATE181064T1 (de) Fibrinogen-rezeptor-antagonisten
ATE135687T1 (de) Perhydroisoindolderivate, ihre herstellung und diese enthaltende arzneimittel
NZ510551A (en) Substituted 3-cyanoquinolines useful as protein tyrosine kinases inhibitors
ATE212022T1 (de) Chinazolinverbindungen
FI901739A0 (fi) Bensimidazoler, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
ATE219077T1 (de) Endothelin antagoniste
EA200700047A1 (ru) Новые алкильные производные в качестве метаботропных рецепторов глутамата
DE69017593D1 (de) Substituierte N-(Imidazolyl)alkyl-alanin-Derivate.
CY1106113T1 (el) Παραγωγα 4-φαινυλ-πυριδινης ως ανταγωνιστες του υποδοχεα νευροκινινης-1
PE75199A1 (es) Derivado de quinolina util como antagonista de neuroquinina
PE69398A1 (es) Antagonistas de receptor de benzoxazinona dopamina d4
ATE187717T1 (de) Pyrimidozykloalkanen als angiotensin ii antagonisten.
JO2235B1 (en) Derivatives of phenyl
TR199802552T2 (xx) 5-HT-2C Resept�r kar��tlar� olarak faydal� indolin t�revleri.
DE3787796D1 (de) Anwendung heterozyklischer Derivate zur Herstellung von Arzneimitteln.
ATE194988T1 (de) Bicyclische nonan-und decanverbindungen mit dopamine-rezeptor-affinitaet
MX9603199A (es) Antagonistas de receptores a endotelina.

Legal Events

Date Code Title Description
AE Restoration of lapsed or forfeited application
FG Grant, registration
FD Application declared void or lapsed